Ultrasound of the Hand is Sufficient to Detect Subclinical Inflammation in Rheumatoid Arthritis Remission: a Post Hoc Longitudinal Study

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2017 Oct 6

PMID 28978340

Citations 13

Authors

Hilde Berner Hammer

Tore K Kvien

Lene Terslev

Affiliations

Soon will be listed here.

Abstract

Background: Ultrasound (US) is a sensitive method for detecting joint/tendon inflammation in patients with rheumatoid arthritis (RA). Subclinical inflammation is often found in patients with RA in composite score remission. The purpose of the present study was to explore whether US of only the hands is sufficient to identify subclinical inflammation in patients with established RA in clinical remission.

Methods: A total of 209 patients with established RA (81% women, mean [SD] age 53.3 (13.2) years, disease duration 10.0 [8.8] years) were examined when initiating biologic disease-modifying anti-rheumatic drugs (bDMARDs) and after 6 months (184 patients) and 12 months (152 patients) of follow-up. They were assessed by US (greyscale [GS] and power Doppler [PD] of 36 joints and 4 tendons, scored 0-3) as well as clinical and laboratory examinations, and different disease activity composite scores were calculated. The presence of US synovitis (GS score ≥ 2, PD score ≥ 1 [PD1] and score ≥ 2 [PD2]) in composite score remission was explored.

Results: Remission at 6 and 12 months was achieved in 74 and 59 patients, respectively, for Disease Activity Score based on 28 joints (DAS28); in 37 and 38 patients, respectively, for Clinical Disease Activity Index; in 42 and 42 patients, respectively, for Simplified Disease Activity Index; and in 38 and 35 patients, respectively, for Boolean remission. The percentages of patients in DAS28 remission at 6 months with synovitis in hands/other regions were 73.0%/64.9% for GS, 64.9%/41.9% for PD1 and 32.4%/20.3% for PD2; at 12 months, the corresponding percentages were 61.0%/64.4% for GS, 62.7%/39.0% for PD1 and 44.1%/15.3% for PD2, respectively. PD activity was more often present in the hands (p < 0.001). In patients in various composite scores of remission, US only of the hands identified ≥ 90% of the patients having PD activity in any of the assessed joints/tendons.

Conclusions: A high percentage of patients had US synovitis despite being in clinical remission. US examination performed only of the hands captured ≥ 90% of patients with subclinical inflammation and could be feasible for assessing bDMARD-treated patients with RA in remission.

Trial Registration: Australian New Zealand Clinical Trials Registry, ACTRN12610000284066 . Registered on 8 April 2010.

Citing Articles

Practical Use of Ultrasound in Modern Rheumatology-From A to Z.

Sapundzhieva T, Sapundzhiev L, Batalov A Life (Basel). 2024; 14(9).

PMID: 39337990 PMC: 11433054. DOI: 10.3390/life14091208.

Factors associated with subclinical inflammation of wrist joints in rheumatoid arthritis patients with low or no disease activity- a RA ultrasound registry study.

Wang Y, Chen J, Ko C, Cheng T, Chiu W, Yu S BMC Musculoskelet Disord. 2023; 24(1):438.

PMID: 37254118 PMC: 10228008. DOI: 10.1186/s12891-023-06521-8.

Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors.

Terslev L, Ostergaard M, Georgiadis S, Brahe C, Ellegaard K, Dohn U RMD Open. 2022; 8(2).

PMID: 36549857 PMC: 9791469. DOI: 10.1136/rmdopen-2022-002796.

Rheumatoid Arthritis Relapse and Remission - Advancing Our Predictive Capability Using Modern Imaging.

Terslev L, Ostergaard M J Inflamm Res. 2021; 14:2547-2555.

PMID: 34163211 PMC: 8215903. DOI: 10.2147/JIR.S284405.

Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission.

Hector C, Millan A, Diaz-Torne C Mediterr J Rheumatol. 2021; 31(4):384-388.

PMID: 33521569 PMC: 7841096. DOI: 10.31138/mjr.31.4.384.

References

Brown A, Quinn M, Karim Z, Conaghan P, Peterfy C, Hensor E . Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 2006; 54(12):3761-73. DOI: 10.1002/art.22190. View

Aletaha D, Nell V, Stamm T, Uffmann M, Pflugbeil S, Machold K . Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005; 7(4):R796-806. PMC: 1175030. DOI: 10.1186/ar1740. View

Scire C, Montecucco C, Codullo V, Epis O, Todoerti M, Caporali R . Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology (Oxford). 2009; 48(9):1092-7. DOI: 10.1093/rheumatology/kep171. View

Millot F, Clavel G, Etchepare F, Gandjbakhch F, Grados F, Saraux A . Musculoskeletal ultrasonography in healthy subjects and ultrasound criteria for early arthritis (the ESPOIR cohort). J Rheumatol. 2011; 38(4):613-20. DOI: 10.3899/jrheum.100379. View

Smolen J, Breedveld F, Schiff M, Kalden J, Emery P, Eberl G . A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003; 42(2):244-57. DOI: 10.1093/rheumatology/keg072. View

Ammitzboll-Danielsen M, Ostergaard M, Naredo E, Terslev L . Validity and sensitivity to change of the semi-quantitative OMERACT ultrasound scoring system for tenosynovitis in patients with rheumatoid arthritis. Rheumatology (Oxford). 2016; 55(12):2156-2166. DOI: 10.1093/rheumatology/kew317. View

Hammer H, Kvien T . Ultrasonography shows significant improvement in wrist and ankle tenosynovitis in rheumatoid arthritis patients treated with adalimumab. Scand J Rheumatol. 2010; 40(3):178-82. DOI: 10.3109/03009742.2010.517549. View

Padovano I, Costantino F, Breban M, DAgostino M . Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis. 2015; 75(10):1819-23. DOI: 10.1136/annrheumdis-2015-208103. View

Aydin S, Gunal E, Ozata M, Keskin H, Ozturk A, Emery P . Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission. Clin Exp Rheumatol. 2017; 35(5):853-856. View

10.

Molenaar E, Voskuyl A, Dinant H, Bezemer P, Boers M, Dijkmans B . Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004; 50(1):36-42. DOI: 10.1002/art.11481. View

11.

Prevoo M, van t Hof M, Kuper H, van Leeuwen M, van de Putte L, van Riel P . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38(1):44-8. DOI: 10.1002/art.1780380107. View

12.

Witt M, Mueller F, Nigg A, Reindl C, Leipe J, Proft F . Relevance of grade 1 gray-scale ultrasound findings in wrists and small joints to the assessment of subclinical synovitis in rheumatoid arthritis. Arthritis Rheum. 2013; 65(7):1694-701. DOI: 10.1002/art.37954. View

13.

Markusse I, Dirven L, Gerards A, van Groenendael J, Ronday H, Kerstens P . Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study. Arthritis Res Ther. 2015; 17:232. PMC: 4553940. DOI: 10.1186/s13075-015-0730-2. View

14.

Brown A, Conaghan P, Karim Z, Quinn M, Ikeda K, Peterfy C . An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008; 58(10):2958-67. DOI: 10.1002/art.23945. View

15.

Saleem B, Brown A, Quinn M, Karim Z, Hensor E, Conaghan P . Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study. Ann Rheum Dis. 2012; 71(8):1316-21. DOI: 10.1136/annrheumdis-2011-200548. View

16.

Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M . Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis. 2016; 75(6):1043-50. DOI: 10.1136/annrheumdis-2015-208941. View

17.

Hammer H, Kvien T, Terslev L . Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation. Clin Exp Rheumatol. 2017; 35(6):959-965. View

18.

Terslev L, Torp-Pedersen S, Qvistgaard E, von der Recke P, Bliddal H . Doppler ultrasound findings in healthy wrists and finger joints. Ann Rheum Dis. 2004; 63(6):644-8. PMC: 1755031. DOI: 10.1136/ard.2003.009548. View

19.

Iwamoto T, Ikeda K, Hosokawa J, Yamagata M, Tanaka S, Norimoto A . Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual.... Arthritis Care Res (Hoboken). 2014; 66(10):1576-81. DOI: 10.1002/acr.22303. View

20.

Aga A, Hammer H, Olsen I, Uhlig T, Kvien T, van der Heijde D . First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach. Ann Rheum Dis. 2015; 75(8):1444-51. DOI: 10.1136/annrheumdis-2015-207572. View